Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey

Journal of the Neurological Sciences

Volumn 280, Issue 1-2, 2009, Pages 22-28

  Ishizu, Takaaki ^a   Kira, Jun ichi ^a   Osoegawa, Manabu ^a   Fukazawa, Toshiyuki ^b   Kikuchi, Seiji ^c   Fujihara, Kazuo ^d   Matsui, Makoto ^e   Kohriyama, Tatsuo ^f   Sobue, Gen ^g   Yamamura, Takashi ^h   Itoyama, Yasuto ^d   Saida, Takahiko ⁱ   Sakata, Kiyomi ^j  

^a KYUSHU UNIVERSITY   (Japan)

^b Nishimaruyama Hospital   (Japan)

^c HOKKAIDO MEDICAL CENTER   (Japan)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KANAZAWA MEDICAL UNIVERSITY   (Japan)

^f HIROSHIMA UNIVERSITY   (Japan)

^g NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

ⁱ UTANO NATIONAL HOSPITAL   (Japan)

^j IWATE MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

Conventional form; Epidemiology; Japanese; Magnetic resonance imaging; Multiple sclerosis; Neuromyelitis optica; Optic spinal form

Indexed keywords

GADOLINIUM; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN DAMAGE; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONTROLLED STUDY; CONVENTIONAL MULTIPLE SCLEROSIS; DISEASE COURSE; DISEASE DURATION; EPIDEMIOLOGICAL DATA; FEMALE; GENETIC HETEROGENEITY; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH SURVEY; HUMAN; JAPANESE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELITIS; NEUTROPHILIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC SPINAL MULTIPLE SCLEROSIS; PHENOTYPE; PLEOCYTOSIS; PREVALENCE; PRIORITY JOURNAL; SPINAL CORD LESION; VISUAL IMPAIRMENT;

ADULT; AGE OF ONSET; BRAIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; JAPAN; LEUKOCYTOSIS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE; NEUTROPHILS; PHENOTYPE; QUESTIONNAIRES; SPINAL CORD; VISION DISORDERS;

EID: 63349090713     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.01.008     Document Type: Article

References (24)

1. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2 (2003) 117-127
2. Kira J., Kanai T., Nishimura Y., Yamasaki K., Matsushita S., Kawano Y., et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 40 (1996) 569-574
3. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
4. Su J.J., Osoegawa M., Minohara M., Tanaka M., Ishizu T., Mihara F., et al. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J Neurol Sci 243 (2006) 21-30
5. Minohara M., Matsuoka T., Li W., Osoegawa M., Ishizu T., Ohyagi Y., et al. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J Neuroimmunol 178 (2006) 156-160
6. Kuroiwa Y., Igata A., Itahara K., Koshijima S., and Tsubaki T. Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases. Neurology 25 (1975) 845-851
7. Shibasaki H., Kubo N., Nishitani H., Saida T., Ohno Y., and Fukuyama Y. Nationwide survey of multiple sclerosis in Japan: reappraisal of clinical features. J Trop Geogr Neurol 2 (1992) 73-82
8. M. Osoegawa, J. Kira, T. Fukazawa, K. Fujihara, S. Kikuchi, M. Matsui, et al. (in press). Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler.
9. Matsuoka T., Matsushita T., Osoegawa M., Ochi H., Kawano Y., Mihara F., et al. Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings. J Neurol Sci 266 (2008) 115-125
10. Matsuoka T., Matsushita T., Osoegawa M., Kawano Y., Minohara M., Mihara F., et al. Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis. Mult Scler 14 (2008) 1181-1190
11. Miura K., Nakagawa H., Morikawa Y., Sasayama S., Matsumori A., Hasegawa K., et al. Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey. Heart 87 (2002) 126-130
12. Schumacher G.A., Beebe G.W., Kibler R.F., Kurland L.T., Kurtzke J.F., McDowell F., et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci 122 (1965) 552-568
13. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
14. Barkhof F., Filippi M., Miller D.H., Scheltens P., Campi A., Polman C.H., et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120 (1997) 2059-2069
15. Hashimoto S., Fukutomi K., Nagai M., Nakamura Y., Yanagawa H., Sasaki R., et al. Response bias in the nationwide epidemiological survey of an intractable disease in Japan. J Epidemiol 1 (1991) 27-30
16. Saida T., Tashiro K., Itoyama Y., Sato T., Ohashi Y., and Zhao Z. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology 64 (2005) 621-630
17. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364 (2004) 2106-2112
18. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., and Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202 (2005) 473-477
19. Nakashima I., Fujihara K., Miyazawa I., Misu T., Narikawa K., Nakamura M., et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77 (2006) 1073-1075
20. Weinshenker B.G., Wingerchuk D.M., Nakashima I., Fujihara K., and Lennon V.A. OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol 5 (2006) 110-111
21. Matsuoka T., Matsushita T., Kawano Y., Osoegawa M., Ochi H., Ishizu T., et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 130 (2007) 1206-1223
22. Tanaka K., Tani T., Tanaka M., Saida T., Idezuka J., Yamazaki M., et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 13 (2007) 850-855
23. Nakashima I., Fukazawa T., Ota K., Nohara C., Warabi Y., Ohashi T., et al. Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features. J Neurol 254 (2007) 488-492
24. Ikuta F., Koga M., Takeda S., Ohama E., Takeshita I., Ogawa H., et al. Comparison of MS pathology between 70 American and 75 Japanese autopsy cases. In: Kuroiwa Y., and Kurland L.T. (Eds). Multiple sclerosis East and West (1982), Kyushu University Press, Fukuoka 297 3-306